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Innovations
Benitec, Ltd.
Gene Silencing from Down Under
of choice. However, in animal mod- vectors allow for permanent gene
els, the same technique was not ap- suppression, as they readily and sta-
plicable because the introduction of bly integrate into the chromosome at
“If you could invent a tool to allow
you to affect gene function and also
give you a generic or universal thera-
peutic, you couldn’t think of any- dsRNAs longer than 30 nt elicited a site directed by the vector’s gene
thing better.” Ken Reed, PhD, Direc- a cell autonomous stress response targeting sequence. For transient
tor of Research and Technology at resulting in cell stasis or apoptosis. suppression, Benitec takes advan-
Benitec, Ltd., has been researching Shorter fragments of 21–25 nt siRNA tage of adenoviruses since these do
RNAi for the past several years and were successfully introduced into not integrate into the chromosome
still speaks with great enthusiasm animals, but these short duplexes but survive independently within the
and amazement when discussing were only effective for a limited num- cell. Furthermore, adenoviruses can
the novelty of RNAi and how Benitec ber of days. What the drug discovery be manipulated to thrive only for a
technology makes use of nature’s community desired and needed was defined period of time, from a few
own cutting-edge capabilities. continuous expression of the spe- weeks to a few months. More re-
Hailed by Science as “2002’s cific dsRNA without eliciting the cell cently, Benitec has successfully
Breakthrough of the Year,” RNA, autonomous stress response. used lentiviruses to introduce RNAi
which has always played second fid- “It is very, very, very difficult to into mice. As observed in melanoma
dle to DNA, is now credited as the get bare nucleic acids into cells in cell lines, in transgenic mice with
molecule behind the gene silencing a living animal,” explains Dr. Reed. induced melanoma, ddRNAi sup-
mechanism of RNA interference Less than a year ago, discussions at pressed expression of the culprit on-
(RNAi), plants’ natural defense mech- cogene.
anism against transposons and vi- Dr. Reed clarifies that science
ruses, and also potentially involved has seen a fast rise in RNAi’s poten-“Can you believe that ain tissue differentiation in mamma- tial as a therapy compared withproperty of cells of alllian cells. While the crucial question other more arduous gene therapies
of why RNAi emerged in mammalian multicellular organisms because RNAi involves shutting
cells remains unanswered, Benitec down the expression of a gene, asthat is this universal, thisis steadily pursuing the therapeutic opposed to the replacement of apotent, and this brilliantbenefits of targeted mammalian gene gene. While the ddRNAi approach
suppression using specific synthe- wasn’t discovered until will not work as well for those dis-
tic RNAi. eases caused by rogue genes, it1998? It’s nature’s best-In mammalian cells, small dou- works well for viral diseases andkept secret.” – Ken Reed,ble-stranded (ds) short hairpin RNAs cancers, in which the disease-caus-
that result from an unknown signal- PhD, Director of Re- ing genes are not essential.
ing mechanism interact with the “The specificity of this is bril-search and Technology,RNase-III-like enzyme named Dicer. liant,” says Reed. He explains thatBenitecDicer then cleaves the hairpin current drug therapies target ap-
dsRNA into 21–25 nt length dsRNA,
proximately 500 proteins out of an
called siRNA (small interfering RNA),
estimated 5,000 “druggable” tar-an RNAi conference focused heavilywhich is then incorporated into a
gets. Reed continues, “It is difficulton how best to package and delivermultisubunit protein complex called
to find a small molecule that will hitRNAi. Benitec found a solution withthe RNA-induced silencing complex
one target and nothing else.” It istheir DNA directed RNAi (ddRNAi)(RISC). The process of coupling
self-evident that an RNA sequencetechnology, which first introduces asiRNA with RISC mediates degrada-
confers absolute specificity. A vari-DNA construct into a cell, allowingtion of any RNA that shares a similar
ety of promoters to be used withthe longer dsRNA to be transcribedsequence to the siRNA, effectively
these DNA constructs provide con-from this sequence intracellularlysilencing the respective gene.
trol of this specific sequence in hu-and thus evading the cell autono-Discovery of this phenomenon
man and animal models. Promotersmous stress response. With this ap-immediately spurred research into
ensure that the DNA is robustly tran-proach, Benitec has successfullyhow scientists could use this mech-
scribed, providing the cell with con-anism to control gene suppression, used lentiviruses to deliver RNAi into
tinual dsRNA. Additionally, by usingi.e., silencing particular genes by in- hippocampal neuron cells. And, un-
a promoter that is only active in cer-troducing synthetic siRNAs into like other viral vectors, lentiviral vec-
tain cell types, another layer of con-cells. Early attempts in nematodes tors do not need to be injected into
trol can be obtained. Reed adds thatas well as cultured mammalian cells the cell nucleus but simply into the
cell itself. Furthermore, lentiviralproved successful in silencing genes the vectors can be cell-type speci-
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fic too, facilitating control of this search from Queensland’s Depart- write to the editors at chembiol@
cell.com.ddRNAi technology on many levels. ment of Primary Industries (DPI).
One of the most fascinating as- Since issuance of their 1998 ddRNAi
Nicole L. Ballew is a freelance science writerpects of RNAi is the road to its dis- patent in mid 2003, Benitec has had
based in Lebanon, NH (nballew@hotmail.covery. Reed exclaims, “Can you dominant patent position for ddRNAi com).
believe that a property of cells of all gene silencing. In the fall of 2003,
multicellular organisms that is this Benitec announced success in dis-
universal, this potent, and this bril- abling multiple genes simultane-
liant wasn’t discovered until 1998? ously using ddRNAi. The ability to
It’s nature’s best-kept secret.” RNAi silence multiple genes lowers the
was discovered serendipitously in possibility that any one cell or virus
plant research. In the 80s, it was can develop resistance to an RNA
noted that certain transgenes in interference treatment. Most can-
plants were becoming less and less cers and HIV, in particular, have high
effective through successive gener- mutation rates. Additionally, type II
ations. In 1990, Dr. Richard Jorgen- diabetes, autoimmune disorders, and
sen, in an effort to make “bluer” pe- cardiovascular dysfunctions result
tunias, inserted an extra copy of the from multiple gene defects. Thus,
“blue” gene into plants. In addition multiple gene silencing would prove
to blue flowers, some of the plant highly beneficial for many condi-
progeny produced all white flowers. tions. At present, Benitec has been
It was then observed that an endog- successful with simultaneously si-
enous gene could be turned off with lencing three genes, and they are
the transformation of an extra copy currently working on increasing this
of that same gene. These transgenic number. The approach to multiple
plants were observed to have an gene silencing is quite similar to the
abundance of messenger RNA, single gene ddRNAi approach. The
which was subsequently destroyed. viral DNA vector encodes for several
With further study in several organ- genes separated by short non-
isms, the marvel mechanism of RNAi sense sequences.
was subsequently revealed. In addition to therapeutic gene
It is thought that RNAi is a signifi- silencing, Benitec is interested in us-
cant component of the plant defense ing ddRNAi in genomic studies to
mechanism. This defense most likely ascertain the biological function of
evolved against transposons, which genes. Similarly, they are using
are so virulent that without a count- ddRNAi for disease modeling. In cul-
ering mechanism an organism will tured cells and animal models, genes
go extinct in a few generations. Reed that are suspected to be causal to
explains, “Plants really do [have] it a disease can be silenced, and the
tough—they are rooted in the ground, result can be analyzed for future
they can’t escape, they can’t evade treatments. Also, target validation
things that worry them, they don’t can be carried out with ddRNAi to
have a systemic immune system, determine if a known disease-asso-
and yet they have to endure all the ciated gene is likely to result in a
abuses that mammalians are subject therapeutic effect.
to but under greater constraints.” For Benitec is fortunate to be in the
mammals, however, the natural role driver’s seat on this emerging tech-
of RNAi is not as clear. RNAi does not nology. Amazingly, this natural mech-
appear to have a role against viruses
anism discovered within the last de-
in mammals, but it is thought to partic-
cade is now recognized worldwide asipate in cell differentiation. Despite
the simplest and most precise methodthe differences and unknowns, it
for shutting down the activity of anywas Dr. Michael Graham who made
specific gene. At this stage, Benitec,the astute revelation that this RNAi
with its patent strength and surpris-phenomenon he first came across
ingly small work force of eight scien-in plants was a general mechanism
tists, is seeking relocation to theand not plant specific. Graham, who
States. Benitec is no doubt sittinghas been studying RNAi for the past
on a goldmine of science discoveryseven years, is Benitec’s Principal
and entrepreneurial success.Inventor and Research Scientist.
Located in Queensland, Austra-
Chemistry & Biology invites yourlia, Benitec was founded in 1997 to
develop and commercialize re- comments on this topic. Please
